IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms13525.html
   My bibliography  Save this article

Amplification of USP13 drives ovarian cancer metabolism

Author

Listed:
  • Cecil Han

    (The University of Texas MD Anderson Cancer Center)

  • Lifeng Yang

    (Rice University)

  • Hyun Ho Choi

    (The University of Texas MD Anderson Cancer Center)

  • Joelle Baddour

    (Rice University)

  • Abhinav Achreja

    (Rice University)

  • Yunhua Liu

    (The University of Texas MD Anderson Cancer Center)

  • Yujing Li

    (The University of Texas MD Anderson Cancer Center)

  • Jiada Li

    (The State Key Laboratory of Medical Genetics and School of Life Sciences, Central South University)

  • Guohui Wan

    (The University of Texas MD Anderson Cancer Center)

  • Cheng Huang

    (Drug Discovery Laboratory, School of Pharmacy, Shanghai University of Traditional Chinese Medicine)

  • Guang Ji

    (Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine)

  • Xinna Zhang

    (The University of Texas MD Anderson Cancer Center)

  • Deepak Nagrath

    (Rice University
    Rice University)

  • Xiongbin Lu

    (The University of Texas MD Anderson Cancer Center)

Abstract

Dysregulated energetic metabolism has been recently identified as a hallmark of cancer. Although mutations in metabolic enzymes hardwire metabolism to tumourigenesis, they are relatively infrequent in ovarian cancer. More often, cancer metabolism is re-engineered by altered abundance and activity of the metabolic enzymes. Here we identify ubiquitin-specific peptidase 13 (USP13) as a master regulator that drives ovarian cancer metabolism. USP13 specifically deubiquitinates and thus upregulates ATP citrate lyase and oxoglutarate dehydrogenase, two key enzymes that determine mitochondrial respiration, glutaminolysis and fatty acid synthesis. The USP13 gene is co-amplified with PIK3CA in 29.3% of high-grade serous ovarian cancers and its overexpression is significantly associated with poor clinical outcome. Inhibiting USP13 remarkably suppresses ovarian tumour progression and sensitizes tumour cells to the treatment of PI3K/AKT inhibitor. Our results reveal an important metabolism-centric role of USP13, which may lead to potential therapeutics targeting USP13 in ovarian cancers.

Suggested Citation

  • Cecil Han & Lifeng Yang & Hyun Ho Choi & Joelle Baddour & Abhinav Achreja & Yunhua Liu & Yujing Li & Jiada Li & Guohui Wan & Cheng Huang & Guang Ji & Xinna Zhang & Deepak Nagrath & Xiongbin Lu, 2016. "Amplification of USP13 drives ovarian cancer metabolism," Nature Communications, Nature, vol. 7(1), pages 1-16, December.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13525
    DOI: 10.1038/ncomms13525
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms13525
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms13525?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms13525. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.